Berta Casar

1.4k total citations
32 papers, 931 citations indexed

About

Berta Casar is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Berta Casar has authored 32 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cell Biology. Recurrent topics in Berta Casar's work include Melanoma and MAPK Pathways (12 papers), Protein Kinase Regulation and GTPase Signaling (11 papers) and Genomics and Chromatin Dynamics (5 papers). Berta Casar is often cited by papers focused on Melanoma and MAPK Pathways (12 papers), Protein Kinase Regulation and GTPase Signaling (11 papers) and Genomics and Chromatin Dynamics (5 papers). Berta Casar collaborates with scholars based in Spain, United States and United Kingdom. Berta Casar's co-authors include Piero Crespo, Adán Pinto, Vicente Andrés, José María González, Victoria Sanz‐Moreno, J. P. Quigley, Elena I. Deryugina, Javier Rodríguez, Lorena Agudo‐Ibáñez and Sanford J. Shattil and has published in prestigious journals such as Nature Communications, The Journal of Cell Biology and The EMBO Journal.

In The Last Decade

Berta Casar

32 papers receiving 922 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Berta Casar Spain 16 750 190 168 89 72 32 931
Michael E. Feigin United States 16 708 0.9× 180 0.9× 214 1.3× 119 1.3× 26 0.4× 26 914
Cynthia López‐Haber United States 15 605 0.8× 171 0.9× 207 1.2× 100 1.1× 29 0.4× 19 824
Masamichi Imajo Japan 13 661 0.9× 420 2.2× 200 1.2× 119 1.3× 49 0.7× 22 1.0k
Catherine Leroy France 18 694 0.9× 99 0.5× 174 1.0× 86 1.0× 89 1.2× 33 1.0k
María Sol Degese Argentina 8 584 0.8× 320 1.7× 186 1.1× 87 1.0× 29 0.4× 8 894
Yuho Hayashi United States 9 469 0.6× 144 0.8× 174 1.0× 135 1.5× 62 0.9× 10 734
Annette Lane Australia 6 663 0.9× 153 0.8× 181 1.1× 80 0.9× 47 0.7× 7 782
Steven T. Sizemore United States 17 584 0.8× 91 0.5× 300 1.8× 186 2.1× 84 1.2× 33 840
Caroline Smales United Kingdom 12 557 0.7× 173 0.9× 174 1.0× 100 1.1× 38 0.5× 14 870
Satoko Ito Japan 21 779 1.0× 217 1.1× 234 1.4× 216 2.4× 45 0.6× 47 1.1k

Countries citing papers authored by Berta Casar

Since Specialization
Citations

This map shows the geographic impact of Berta Casar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berta Casar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berta Casar more than expected).

Fields of papers citing papers by Berta Casar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berta Casar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berta Casar. The network helps show where Berta Casar may publish in the future.

Co-authorship network of co-authors of Berta Casar

This figure shows the co-authorship network connecting the top 25 collaborators of Berta Casar. A scholar is included among the top collaborators of Berta Casar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Berta Casar. Berta Casar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conde, Javier, Isabel Fernández‐Pisonero, L. Francisco Lorenzo‐Martín, et al.. (2024). The mevalonate pathway contributes to breast primary tumorigenesis and lung metastasis. Molecular Oncology. 19(1). 56–80. 4 indexed citations
2.
Piperi, Christina, et al.. (2024). Combination of JAKi and HDACi Exerts Antiangiogenic Potential in Cutaneous T-Cell Lymphoma. Cancers. 16(18). 3176–3176. 1 indexed citations
3.
Casar, Berta, et al.. (2024). DNA damage signalling histone H2AX is required for tumour growth. Cell Death Discovery. 10(1). 99–99. 6 indexed citations
4.
Rodríguez, Javier, Alex von Kriegsheim, Michael Grusch, et al.. (2024). ERK 1/2 mitogen‐activated protein kinase dimerization is essential for the regulation of cell motility. Molecular Oncology. 19(2). 452–473. 5 indexed citations
5.
Moreno-Rodriguez, Thaidy, Laura González-Silva, Carlos Revilla, et al.. (2021). ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer. Oncogene. 40(16). 2923–2935. 24 indexed citations
6.
Casar, Berta, Anna Esteve‐Codina, Marta Gut, et al.. (2021). PLCγ1/PKCθ Downstream Signaling Controls Cutaneous T-Cell Lymphoma Development and Progression. Journal of Investigative Dermatology. 142(5). 1391–1400.e15. 8 indexed citations
7.
Rodrigo, Miguel Ángel Merlos, Berta Casar, Hana Michalkova, et al.. (2021). Extending the Applicability of In Ovo and Ex Ovo Chicken Chorioallantoic Membrane Assays to Study Cytostatic Activity in Neuroblastoma Cells. Frontiers in Oncology. 11. 707366–707366. 21 indexed citations
8.
Rodrigo, Miguel Ángel Merlos, Hana Michalkova, Berta Casar, et al.. (2021). MO38-2 Metallothionein-3: Potential therapeutic target for sorafenib resistance in hepatocellular carcinoma. Annals of Oncology. 32. S323–S323. 1 indexed citations
9.
Rodrigo, Miguel Ángel Merlos, Hana Michalkova, Vladislav Strmiska, et al.. (2021). Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma. Scientific Reports. 11(1). 5496–5496. 17 indexed citations
10.
Casar, Berta, et al.. (2021). RAC1 Activation as a Potential Therapeutic Option in Metastatic Cutaneous Melanoma. Biomolecules. 11(11). 1554–1554. 15 indexed citations
11.
Shackleton, Sue, et al.. (2020). RAC1 induces nuclear alterations through the LINC complex to enhance melanoma invasiveness. Molecular Biology of the Cell. 31(25). 2768–2778. 11 indexed citations
12.
Casar, Berta & Piero Crespo. (2016). ERK Signals: Scaffolding Scaffolds?. Frontiers in Cell and Developmental Biology. 4. 49–49. 24 indexed citations
13.
Herrero, Ana, et al.. (2016). Defined spatiotemporal features of RAS-ERK signals dictate cell fate in MCF-7 mammary epithelial cells. Molecular Biology of the Cell. 27(12). 1958–1968. 18 indexed citations
14.
Agudo‐Ibáñez, Lorena, Piero Crespo, & Berta Casar. (2016). Analysis of Ras/ERK Compartmentalization by Subcellular Fractionation. Methods in molecular biology. 1487. 151–162. 5 indexed citations
15.
Casar, Berta, Ivo Rimann, Hisashi Kato, et al.. (2012). In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling. Oncogene. 33(2). 255–268. 93 indexed citations
16.
Casar, Berta, Yaowu He, Mary Iconomou, et al.. (2011). Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells. Oncogene. 31(35). 3924–3938. 55 indexed citations
17.
Casar, Berta, Adán Pinto, & Piero Crespo. (2009). ERK dimers and scaffold proteins: Unexpected partners for a forgotten (cytoplasmic) task. Cell Cycle. 8(7). 1007–1013. 46 indexed citations
18.
Casar, Berta, Imanol Arozarena, Victoria Sanz‐Moreno, et al.. (2008). Ras Subcellular Localization Defines Extracellular Signal-Regulated Kinase 1 and 2 Substrate Specificity through Distinct Utilization of Scaffold Proteins. Molecular and Cellular Biology. 29(5). 1338–1353. 98 indexed citations
19.
Casar, Berta, Adán Pinto, & Piero Crespo. (2008). Essential Role of ERK Dimers in the Activation of Cytoplasmic but Not Nuclear Substrates by ERK-Scaffold Complexes. Molecular Cell. 31(5). 708–721. 114 indexed citations
20.
Casar, Berta, Victoria Sanz‐Moreno, Mustafa N. Yazicioglu, et al.. (2007). Mxi2 promotes stimulus‐independent ERK nuclear translocation. The EMBO Journal. 26(3). 635–646. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael E. Feigin Breakdown of academic impact, for papers by Cynthia López‐Haber Breakdown of academic impact, for papers by Masamichi Imajo Breakdown of academic impact, for papers by Catherine Leroy Breakdown of academic impact, for papers by María Sol Degese Breakdown of academic impact, for papers by Yuho Hayashi Breakdown of academic impact, for papers by Annette Lane Breakdown of academic impact, for papers by Steven T. Sizemore Breakdown of academic impact, for papers by Caroline Smales Breakdown of academic impact, for papers by Satoko Ito
Rankless by CCL
2026